Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacokinetics (processing by the body) of intravenous and subcutaneous RO7121932 in participants with Mult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• RO7121932

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Multiple Sclerosis | Phase 1 | Status: RECRUITING